Nice one...
Good to see an increase in number of Biomarkers to be observed, namely (but not necessarily limited to):
- COMP
- C terminal telopeptide (CTX) -II
- NGF, interleukin (IL) -1ß,
- TNFa,
- IL-6
- A disintegrin and metalloproteinase with thrombospondin motif 5 (ADAMTS-5),
- ARGS (aggrecan cleavage fragments)
- Tissue inhibitor matrix metalloproteinase 1 (TIMP-1)
- CTX-I
- Type II collagen (C2C)
Quite a comprehensive study also looking at Pain, Function and Stiffness along with Serum samples.
Will be illustrative to get a comparison between Synovium and Serum activity and the effects of iPPS on each.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.005(1.15%) |
Mkt cap ! $170.8M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 40.5¢ | $532.2K | 1.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4500 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 9422 | 3 |
View Market Depth
| Last trade - 16.10pm 10/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |